Pharvaris expects pivotal HAE study data in third quarter 2026

Go back to Pharvaris expects pivotal HAE study data in third quarter 2026
(NASDAQ: PHVS) Delayed: 34.84 -0.07 (0.2%)
Previous Close $34.91    52 Week High
Open $35.00    52 Week Low
Day High $35.67    P/E N/A 
Day Low $34.09    EPS
Volume 982,023